晚期CKD中β-氧化受损及复杂脂质脂肪酸分配改变
该研究基于CPROBE队列214例不同分期CKD患者,用液相色谱-质谱检测17类脂质及酰基肉碱。结果显示长链与中链酰基肉碱比值从CKD 2期至5期逐渐下降(P<0.001),且与多不饱和长链复杂脂质及C16-C20游离脂肪酸呈负相关。
要点
- CKD进展伴随长链与中链酰基肉碱比值逐渐下降,提示β-氧化效率降低。
- CKD 5期饱和C16-C20游离脂肪酸及长链多不饱和复杂脂质丰度升高。
- 酰基肉碱比值与多不饱和长链复杂脂质及C16-C20游离脂肪酸呈负相关。
核心结论
- 饱和C16-C20游离脂肪酸增多、β-氧化受损及向复杂脂质分配改变可能是晚期CKD脂代谢异常的机制。
研究设计与样本
- 从CPROBE队列1235例成人中选取214例:CKD 1-2期36例、3期99例、4期61例、5期18例。
- 男性110例(51.4%),黑人64例(29.9%),白人150例(70.1%),平均年龄60(SD 16)岁。
- 用液相色谱-质谱检测血浆脂质和酰基肉碱,共鉴定17类330种脂质。
主要发现
- 与早期相比,CKD 5期饱和C16-C20游离脂肪酸和长链多不饱和复杂脂质丰度更高。
- 长链与中链酰基肉碱比值从CKD 2期至5期呈梯度下降(P<0.001)。
- 多重线性回归显示该比值与多不饱和长链复杂脂质亚类及C16-C20游离脂肪酸负相关,与双键较少的短链复杂脂质正相关。
临床怎么用
- 长链与中链酰基肉碱比值可作为评估CKD患者β-氧化效率的潜在指标。
- 对晚期CKD患者需关注饱和C16-C20游离脂肪酸及复杂脂质谱的改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Studies of lipids in CKD, including ESRD, have been limited to measures of conventional lipid profiles. We aimed to systematically identify 17 different lipid classes and associate the abundance thereof with alterations in acylcarnitines, a metric of β-oxidation, across stages of CKD. From the Clinical Phenotyping Resource and Biobank Core (CPROBE) cohort of 1235 adults, we selected a panel of 214 participants: 36 with stage 1 or 2 CKD, 99 with stage 3 CKD, 61 with stage 4 CKD, and 18 with stage 5 CKD. Among participants, 110 were men (51.4%), 64 were black (29.9%), and 150 were white (70.1%), and the mean (SD) age was 60 (16) years old. We measured plasma lipids and acylcarnitines using liquid chromatography-mass spectrometry. Overall, we identified 330 different lipids across 17 different classes. Compared with earlier stages, stage 5 CKD associated with a higher abundance of saturated C16-C20 free fatty acids (FFAs) and long polyunsaturated complex lipids. Long-chain-to-intermediate-chain acylcarnitine ratio, a marker of efficiency of β-oxidation, exhibited a graded decrease from stage 2 to 5 CKD (P<0.001). Additionally, multiple linear regression revealed that the long-chain-to-intermediate-chain acylcarnitine ratio inversely associated with polyunsaturated long complex lipid subclasses and the C16-C20 FFAs but directly associated with short complex lipids with fewer double bonds. We conclude that increased abundance of saturated C16-C20 FFAs coupled with impaired β-oxidation of FFAs and inverse partitioning into complex lipids may be mechanisms underpinning lipid metabolism changes that typify advancing CKD.
引用
- Afshinnia F, Rajendiran TM, Soni T, et al. Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD. J Am Soc Nephrol. 2017. PMID: 29021384. doi:10.1681/ASN.2017030350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。